The Liver Meeting 2019-HCC Prevention, Biomarkers and Community Outreach

HCC Prevention, Biomarkers and Community Outreach – Highlights from the NCI

Video Transcription

Video Summary

The speaker expressed gratitude for being included in an important NIH session focusing on liver cancer research funding from various institutes. They discussed challenges in early detection and biomarker validation for hepatocellular carcinoma, emphasizing the need for improved surveillance and risk stratification, especially in high-risk groups. The NCI initiated a consortium and provided resources like specimen sets for biomarker studies. They highlighted ongoing efforts like the Hepatocellular Early Detection Study and upcoming funding opportunities for cancer research, encouraging collaboration and outreach to program officers for guidance. The importance of seeking advice and engaging with program officers for proposal development was emphasized, including considerations for researchers in industry.

Asset Caption

Presenter: Jo Ann Rinaudo

Keywords

NIH session

liver cancer research funding

early detection

biomarker validation

high-risk groups